Long-term efficacy of teriflunomide in patients recently diagnosed with relapsing forms of MS

被引：0
|
作者：
Freedman, M. [1 ,2 ]
Comi, G. [3 ]
Miller, A. [4 ]
Wolinsky, J. [5 ]
Oh, J. [6 ]
Thangavelu, K. [7 ]
Truffinet, P. [8 ]
Kappos, L. [9 ]
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
[2] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[3] Univ Vita Salute San Raffaele, Milan, Italy
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[5] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[6] St Michaels Hosp, Toronto, ON, Canada
[7] Sanofi Genzyme, Cambridge, MA USA
[8] Sanofi Genzyme, Chilly Mazarin, France
[9] Univ Hosp Basel, Basel, Switzerland
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P31138
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [1] Long-term Efficacy of Teriflunomide in Patients Recently Diagnosed With Relapsing Forms of MS
    Oh, Jiwon
    Freedman, Mark S.
    Miller, Aaron E.
    Thangavelu, Karthinathan
    Truffine, Philippe
    Comi, Giancarlo
    NEUROLOGY, 2017, 88
  • [2] Long-term safety and efficacy of teriflunomide in patients with relapsing forms of multiple sclerosis in the TEMSO extension trial
    Freedman, M.
    Wolinsky, J.
    Comi, G.
    Kappos, L.
    Olsson, T.
    Miller, A.
    Benamor, M.
    Dukovic, D.
    Liang, J.
    Truffinet, P.
    O'Connor, P.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 225 - 225
  • [3] Long-Term Outcomes in Patients With Progressive Forms of Relapsing MS Treated With Teriflunomide: Real-World Evidence
    Nelson, Flavia
    Lebrun-Frenay, Christine
    Boyko, Alexey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cavalier, Steve
    Truffinet, Philippe
    Liang, Jinjun
    Berkovich, Regina
    NEUROLOGY, 2018, 90
  • [4] Long-Term Outcomes in Patients with Progressive Forms of Relapsing MS Treated with Teriflunomide: Real-World Evidence
    Berkovich, Regina
    Thangavelu, Karthinathan
    Cavalier, Steven J.
    Truffinet, Philippe
    Nelson, Flavia
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 20 - 20
  • [5] TERIKIDS Study: teriflunomide efficacy and safety in paediatric patients with relapsing forms of MS
    Chitnis, T.
    Banwell, B.
    Kappos, L.
    Arnold, D. L.
    Gucuyener, K.
    Deiva, K.
    Skripchenko, N.
    Qiu, W.
    Saubadu, S.
    Hu, W.
    Benamor, M.
    Le-Halpere, A.
    Truffinet, P.
    Tardieu, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 46 - 46
  • [6] Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience
    Miller, Aaron E.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (12) : 381 - 396
  • [7] Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study
    Miller, Aaron E.
    Olsson, Tomas P.
    Wolinsky, Jerry S.
    Comi, Giancarlo
    Kappos, Ludwig
    Hu, Xueqiang
    Xu, Xianhao
    Lublin, Alex L.
    Truffinet, Philippe
    Chavin, Jeffrey
    Delhay, Jean-Luc
    Benamor, Myriam
    Purvis, Annie
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [8] Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
    Miller, Aaron E.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (05) : 467 - 483
  • [9] Efficacy and safety of teriflunomide in Chinese patients with relapsing forms of MS: A subgroup analysis of the phase 3 tower study
    Macdonell, R.
    Freedman, M.
    Xu, X.
    Vucic, S.
    Truffinet, P.
    Benamor, M.
    Thangavelu, K.
    Miller, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 135 - 135
  • [10] Long-term safety of teriflunomide: 2.5-year follow-up in the TOWER extension study in patients with relapsing MS
    Freedman, M. S.
    Kappos, L.
    Comi, G.
    Miller, A. E.
    Wolinsky, J. S.
    Thangavelu, K.
    Truffinet, P.
    Benamor, M.
    Rufi, P.
    O'Connor, W.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 761 - 761
12345